Gaia Family Offers AI-Driven IVF Cost Transparency for Hopeful Parents

As of November 16, 2025, a startup called Gaia Family is revolutionizing the in-vitro fertilization (IVF) industry by providing a more transparent and predictable approach to fertility care. The company was founded by Nader AlSalim, a former Goldman Sachs executive who personally experienced the financial and emotional toll of IVF.

Gaia Family's innovative model offers couples a fixed-cost plan for their IVF treatment, medications, and embryo transfers. By using AI-driven forecasting, the company can provide families with a clear roadmap of their expected costs, removing the guesswork and uncertainty that often plagues the IVF journey. If a cycle does not result in viable embryos, Gaia's built-in protections cover another attempt, helping couples try again without the added financial burden.

Once couples have viable embryos, Gaia's plan allows them unlimited frozen embryo transfers at no extra cost until they have a baby. And if none of those transfers lead to a live birth, the company will provide money towards another IVF cycle. Gaia also offers the option to include all PGT-A testing and medications for a fixed cost, providing even more financial security throughout the process.

Gaia Family's mission goes beyond just the technology, as AlSalim explains, "We're using AI not to replace the human element of fertility care, but to bring more confidence to it." By analyzing millions of data points, the company can forecast the most effective and affordable pathway for each individual, empowering couples to make informed decisions during this emotional journey.